A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin vs. Simvastatin Monotherapy in High Risk Subjects Presenting with Acute Coronary Syndrome (IMPROVE IT).

Project: Other project

StatusFinished
Effective start/end date5/17/0612/31/15

Funding

  • Schering-Plough Research Institute: $84,240.00